Propanc Biopharma (PPCB) Other Working Capital Changes (2022 - 2025)
Propanc Biopharma (PPCB) posted quarterly Other Working Capital Changes of -$6151.0 for Q4 2025, down 30.62% year-over-year from -$8866.0 in Q4 2024, and down 325.89% quarter-over-quarter from $2723.0 in Q3 2025.
Propanc Biopharma (PPCB) Other Working Capital Changes (2022 - 2025) Analysis & Trends
Propanc Biopharma (PPCB) has reported Other Working Capital Changes for 4 consecutive years, with -$6151.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Working Capital Changes fell 30.62% year-over-year to -$6151.0; the TTM figure through Dec 2025 stood at -$14561.0 (up 32.0% YoY), while the FY2025 annual figure was -$21722.0, down 0.57% from the prior year.
- Other Working Capital Changes eased to -$6151.0 in Q4 2025 per PPCB's latest filing, from $2723.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $14468.0 in Q3 2023 and bottomed at -$25072.0 in Q1 2023.
- Historically, Other Working Capital Changes has averaged $702.31 across 5 years, with a median of $2768.0 in 2022.
- On a YoY basis, Other Working Capital Changes climbed as much as 146.31% in 2025 and fell as far as 30.62% in 2025.
- Propanc Biopharma's Other Working Capital Changes stood at -$5287.0 in 2022, then dropped by 8.59% to -$5741.0 in 2023, then increased by 17.98% to -$4709.0 in 2024, then slumped by 30.62% to -$6151.0 in 2025.
- Business Quant data shows PPCB's Other Working Capital Changes at -$6151.0 in Q4 2025, $2723.0 in Q3 2025, and -$5512.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Propanc Biopharma | 587,855.41 | 587,855.41 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6,151.00 |
| Dec 31, 2025 | -6,151.00 |
| Dec 31, 2025 | -6,151.00 |
| Sep 30, 2025 | 2,723.00 |
| Sep 30, 2025 | 2,723.00 |
| Sep 30, 2025 | 2,723.00 |
| Jun 30, 2025 | -5,512.00 |
| Jun 30, 2025 | -5,512.00 |
| Jun 30, 2025 | -5,512.00 |
| Mar 31, 2025 | -5,621.00 |
| Mar 31, 2025 | -5,621.00 |
| Mar 31, 2025 | -5,621.00 |
| Dec 31, 2024 | -4,709.00 |
| Dec 31, 2024 | -4,709.00 |
| Dec 31, 2024 | -4,709.00 |
| Sep 30, 2024 | -5,880.00 |
| Sep 30, 2024 | -5,880.00 |
| Sep 30, 2024 | -5,880.00 |
| Jun 30, 2024 | -5,986.00 |
| Jun 30, 2024 | -5,986.00 |